Reassessing the Clinical Interpretation of Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma.
0/5 보강
APA
Xiang Z, Xu Y, et al. (2026). Reassessing the Clinical Interpretation of Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma.. Liver international : official journal of the International Association for the Study of the Liver, 46(2), e70510. https://doi.org/10.1111/liv.70510
MLA
Xiang Z, et al.. "Reassessing the Clinical Interpretation of Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma.." Liver international : official journal of the International Association for the Study of the Liver, vol. 46, no. 2, 2026, pp. e70510.
PMID
41489125 ↗
같은 제1저자의 인용 많은 논문 (5)
- CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma.
- WDHD1 promotes hepatocellular carcinoma progression by affecting the cell cycle and immune evasion.
- Efficacy and safety of ultra-hypofractionated post-operative radiation therapy for breast cancer: a systematic review and meta-analysis.
- Serologic detection of regenerating protein I alpha by time-resolved fluoroimmunoassay and its clinical value in gastric cancer.
- Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis.